Tuixent Escribà
Impact in
- Virology top 10%
- HIV Research and Treatment
- Emergency Medicine top 10%
- HIV-related health complications and treatments
Papers in
- Virology 5
- HIV Research and Treatment 5
-
- Gut microbiota and health 2
- Co-authors
- Mireia Arnedo (9 shared papers)Lander Egaña-Gorroño (8 shared papers)Felipe García (4 shared papers)Estebán Martínez (5 shared papers)José María Gatell (3 shared papers)Alberto C. Guardo (3 shared papers)José M. Gatell (4 shared papers)Bru Cormand (1 shared paper)
- Journals
- Vaccines (2 papers)PLoS ONE (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Frontiers in Immunology (1 paper)Journal of Lipid Research (1 paper)
- Partner nations
- SpainUnited StatesGermany
In The Last Decade
Tuixent Escribà
13 papers receiving 174 citations
Peers
Comparison fields: 5 of 48
- Virology 53
- Emergency Medicine 43
- Cancer Research 42
- Infectious Diseases 30
- Immunology 21
Countries citing papers authored by Tuixent Escribà
This map shows the geographic impact of Tuixent Escribà's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tuixent Escribà with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tuixent Escribà more than expected).
Fields of papers citing papers by Tuixent Escribà
This network shows the impact of papers produced by Tuixent Escribà. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tuixent Escribà. The network helps show where Tuixent Escribà may publish in the future.
Co-authors
The 25 scholars most cited alongside Tuixent Escribà, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 47 | |
| 2 | 2012 | 27 | |
| 3 | 2018 | 25 | |
| 4 | 2016 | 20 | |
| 5 | 2018 | 14 | |
| 6 | 2022 | 12 | |
| 7 | 2014 | 9 | |
| 8 | 2021 | 8 | |
| 9 | 2016 | 7 | |
| 10 | 2014 | 3 | |
| 11 | 2012 | 2 | |
| 12 | 2024 | 2 | |
| 13 | 2023 | 2 |
About Tuixent Escribà
Tuixent Escribà is a scholar working on Virology, Molecular Biology, Emergency Medicine, Infectious Diseases and Pathology and Forensic Medicine, having authored 13 papers that have together received 178 indexed citations. Recurring topics across this work include HIV Research and Treatment (5 papers), HIV-related health complications and treatments (4 papers), Gut microbiota and health (2 papers), Clostridium difficile and Clostridium perfringens research (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Metal-Organic Frameworks: Synthesis and Applications (1 paper), Vitamin D Research Studies (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Virology (53 citations), Emergency Medicine (43 citations), Cancer Research (42 citations), Infectious Diseases (30 citations) and Immunology (21 citations). Tuixent Escribà has collaborated with scholars based in Spain, United States and Germany. Frequent co-authors include Mireia Arnedo, Lander Egaña-Gorroño, Felipe García, Estebán Martínez, José María Gatell, Alberto C. Guardo, José M. Gatell, Bru Cormand, Agathe León and Montserrat Plana. Their work appears in journals such as Vaccines, PLoS ONE, Antimicrobial Agents and Chemotherapy, Frontiers in Immunology and Journal of Lipid Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.